Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$15.92 - $20.69 $76,782 - $99,787
4,823 Added 36.04%
18,207 $300,000
Q4 2023

Feb 14, 2024

SELL
$6.73 - $18.28 $3,728 - $10,127
-554 Reduced 3.97%
13,384 $237,000
Q3 2023

Nov 14, 2023

BUY
$9.2 - $14.12 $128,229 - $196,804
13,938 New
13,938 $131,000
Q4 2022

Feb 14, 2023

BUY
$6.86 - $10.65 $272,232 - $422,634
39,684 Added 3.39%
1,210,417 $11.3 Million
Q3 2022

Nov 14, 2022

SELL
$9.37 - $19.88 $705,795 - $1.5 Million
-75,325 Reduced 6.05%
1,170,733 $11.6 Million
Q2 2022

Aug 15, 2022

BUY
$16.01 - $27.99 $2.35 Million - $4.12 Million
147,032 Added 13.38%
1,246,058 $19.9 Million
Q1 2022

May 16, 2022

BUY
$22.47 - $45.75 $24.7 Million - $50.3 Million
1,099,026 New
1,099,026 $25.1 Million

Others Institutions Holding ZIMV

About ZimVie Inc.


  • Ticker ZIMV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,084,000
  • Market Cap $361M
  • Description
  • ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bo...
More about ZIMV
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.